Bilypsa 4mg Tablets contain Saroglitazar, a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist developed to treat diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes mellitus who are not adequately controlled with statins alone.
It works by reducing triglyceride levels and improving insulin sensitivity, thereby offering both lipid-lowering and glycemic control benefits.
Bilypsa is particularly useful in managing atherogenic dyslipidemia, a key cardiovascular risk factor in diabetic patients. The usual dose is one tablet daily, taken orally, with or without food, as prescribed by a physician.
Common side effects may include gastric discomfort, elevated liver enzymes, or muscle pain, though it is generally well-tolerated.
Find products similar to 4mg Bilypsa Saroglitazar Tablets
